ROME Therapeutics
Kira Nelson stepped into her role as ROME’s senior vice president of finance with a depth of experience in biotech finance and operations. She was most recently the co-founder of N-Squared Financial Consultants, where she helped companies build financial infrastructure, prepared them for initial public offerings and provided guidance in strategic planning, forecasting and internal control development. Kira was also vice president of finance and operations of Aileron Therapeutics and chief financial officer of Omtool, a provider of document capture solutions. She began her career at Arthur Andersen LLP, where she became a certified public accountant. Kira earned a B.A. in economics and accounting from the College of the Holy Cross.
This person is not in any offices
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.”